Loss of Heterozygosity in Normal Tissue Adjacent to Breast Carcinomas
The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
Abstract
Loss of heterozygosity (LOH) was detected in morphologically normal lobules adjacent to breast cancers. The most frequent aberration was at chromosome 3p22-25; of ten cases with this LOH in the carcinoma, six displayed the same LOH in adjacent normal lobules. This suggests that in a subset of sporadic breast cancers, a tumor suppresser gene at 3p22-25 may be important in initiation or early progression of tumorigenesis. Among sixteen breast cancers with LOH at 17p13.1 and five breast cancers with LOH at 11p15.5, one case each displayed the same LOH in adjacent normal lobules. Thus the molecular heterogeneity that characterizes invasive breast cancers may occur at the earliest detectable stages of progression.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A genetic model for colorectal tumorigenesis
Fearon, E. R., & Vogelstein, B. (1990) · Cell · doi:10.1016/0092-8674(90)90186-i · Cited by 12,132
A second-generation linkage map of the human genome
Weissenbach, J., Gyapay, G., Dib, C., Vignal, A., Morissette, J., Millasseau, P., Vaysseix, G., & Lathrop, M. (1992) · Nature · doi:10.1038/359794a0 · Cited by 1,685
c-erbB-2 Expression and Response to Adjuvant Therapy in Women with Node-Positive Early Breast Cancer
Muss, H. B., Thor, A. D., Berry, D. A., Kute, T., Liu, E. T., Koerner, F., Cirrincione, C. T., Budman, D. R., Wood, W. C., Barcos, M., et al. (1994) · New England Journal of Medicine · doi:10.1056/nejm199405053301802 · Cited by 961
Self-citationTetranucleotide repeat polymorphism at the human tyrosine hydroxylase gene (TH)
Polymeropoulos, M. H., Xiao, H., Rath, D. S., & Merril, C. R. (1991) · Nucleic Acids Research · doi:10.1093/nar/19.13.3753 · Cited by 257
The Risk of Breast Cancer after Irradiation of the Thymus in Infancy
Hildreth, N. G., Shore, R. E., & Dvoretsky, P. M. (1989) · New England Journal of Medicine · doi:10.1056/nejm198911093211901 · Cited by 252
Somatic genetic changes in human breast cancer
Devilee, P. (1994) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/0304-419x(94)90009-4 · Cited by 209
Tsai, Y. C., Lü, Y., Nichols, P. W., Zlotnikov, G., Jones, P. A., & Smith, H. S. (1996) · PubMed · Cited by 166
Self-citationLoss of heterozygosity and p53 gene mutations in breast cancer.
Deng, G., Chen, L. C., Schott, D. R., Thor, A. D., Bhargava, V., Ljung, B., Chew, K., & Smith, H. S. (1994) · PubMed · Cited by 141
Self-citationA Hypothesis of the Origin of Human Breast Cancer from the Terminal Ductal Lobular Unit
WELLINGS, S. R. (1980) · Pathology - Research and Practice · doi:10.1016/s0344-0338(80)80248-2 · Cited by 140
Molecular genetic studies of early breast cancer evolution
O'Connell, P., Pekkel, V., Fuqua, S. A. W., Osborne, C. K., & Allred, D. C. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00666201 · Cited by 118
Cited by
Influence of tumour micro-environment heterogeneity on therapeutic response
Junttila, M. R., & de Sauvage, F. J. (2013) · Nature · doi:10.1038/nature12626 · Cited by 2,694
Quantification of mRNA using real-time reverse transcription PCR (RT-PCR): trends and problems
Bustin, S. (2002) · Journal of Molecular Endocrinology · doi:10.1677/jme.0.0290023 · Cited by 2,546
Bissell, M. J., & Radisky, D. (2001) · Nature Reviews Cancer · doi:10.1038/35094059 · Cited by 2,180
Krtolica, A., Parrinello, S., Lockett, S., Desprez, P.-Y., & Campisi, J. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.211053698 · Cited by 1,730
Molecular characterization of the tumor microenvironment in breast cancer
Allinen, M., Beroukhim, R., Cai, L., Brennan, C., Lahti-Domenici, J., Huang, H., Porter, D., Hu, M., Chin, L., Richardson, A., et al. (2004) · Cancer Cell · doi:10.1016/j.ccr.2004.06.010 · Cited by 1,299
Tumors as Organs: Complex Tissues that Interface with the Entire Organism
Egeblad, M., Nakasone, E. S., & Werb, Z. (2010) · Developmental Cell · doi:10.1016/j.devcel.2010.05.012 · Cited by 1,234
Nelson, C. M., & Bissell, M. J. (2006) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.22.010305.104315 · Cited by 1,130
Gene expression profiles of human breast cancer progression
Ma, X.-J., Salunga, R., Tuggle, J. T., Gaudet, J., Enright, E., McQuary, P., Payette, T., Pistone, M., Stecker, K., Zhang, B. M., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0931261100 · Cited by 887
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
Bos, R., Zhong, H., Hanrahan, C. F., Mommers, E. C. M., Semenza, G. L., Pinedo, H. M., Abeloff, M. D., Simons, J. W., van Diest, P. J., & van der Wall, E. (2001) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/93.4.309 · Cited by 593
The genetics and genomics of cancer
Balmain, A., Gray, J., & Ponder, B. (2003) · Nature Genetics · doi:10.1038/ng1107 · Cited by 573
Keeping abreast of the mammary epithelial hierarchy and breast tumorigenesis
Visvader, J. E. (2009) · Genes & Development · doi:10.1101/gad.1849509 · Cited by 571
Clinical, Cellular, and Molecular Aspects of Cancer Invasion
Mareel, M., & Leroy, A. (2003) · Physiological Reviews · doi:10.1152/physrev.00024.2002 · Cited by 524
Cancer and ageing: rival demons?
Campisi, J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1073 · Cited by 512
The tumor microenvironment is a dominant force in multidrug resistance
Correia, A. L., & Bissell, M. J. (2012) · Drug Resistance Updates · doi:10.1016/j.drup.2012.01.006 · Cited by 443
Histological and biological evolution of human premalignant breast disease.
Allred, D. C., Mohsin, S. K., & Fuqua, S. A. (2001) · Endocrine-related cancer · doi:10.1677/erc.0.0080047 · Cited by 416
Cellular senescence, cancer and aging: the telomere connection
Campisi, J., Kim, S.-H., Lim, C.-S., & Rubio, M. (2001) · Experimental Gerontology · doi:10.1016/s0531-5565(01)00160-7 · Cited by 400
Short telomeres on human chromosome 17p
Martens, U. M., Zijlmans, J. M. J. M., Poon, S. S. S., Dragowska, W., Yui, J., Chavez, E. A., Ward, R. K., & Lansdorp, P. M. (1998) · Nature Genetics · doi:10.1038/ng0198-018 · Cited by 393
Momparler, R. L., & Bovenzi, V. (2000) · Journal of Cellular Physiology · doi:10.1002/(sici)1097-4652(200005)183:2<145::aid-jcp1>3.0.co;2-v · Cited by 387
The Reliability Theory of Aging and Longevity
GAVRILOV, L. A., & GAVRILOVA, N. S. (2001) · Journal of Theoretical Biology · doi:10.1006/jtbi.2001.2430 · Cited by 384
Immuno-LCM: Laser Capture Microdissection of Immunostained Frozen Sections for mRNA Analysis
Fend, F., Emmert-Buck, M. R., Chuaqui, R., Cole, K., Lee, J., Liotta, L. A., & Raffeld, M. (1999) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)65251-0 · Cited by 378
Targeting Breast Cancer Stem Cells
Liu, S., & Wicha, M. S. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.5388 · Cited by 356
Breast cancer precursors revisited: molecular features and progression pathways
Lopez‐Garcia, M. A., Geyer, F. C., Lacroix‐Triki, M., Marchió, C., & Reis‐Filho, J. S. (2010) · Histopathology · doi:10.1111/j.1365-2559.2010.03568.x · Cited by 347
Analysis of Loss of Heterozygosity in 399 Premalignant Breast Lesions at 15 Genetic Loci
O'Connell, P., Pekkel, V., Allred, D. C., Fuqua, S. A. W., Osborne, C. K., & Clark, G. M. (1998) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/90.9.697 · Cited by 340
Biospecimen Reporting for Improved Study Quality (BRISQ)
Moore, H. M., Kelly, A. B., Jewell, S. D., McShane, L. M., Clark, D. P., Greenspan, R., Hayes, D. F., Hainaut, P., Kim, P., Mansfield, E., et al. (2011) · Journal of Proteome Research · doi:10.1021/pr200021n · Cited by 337
Wistuba, I. I., Behrens, C., Milchgrub, S., Bryant, D., Hung, J., Minna, J. D., & Gazdar, A. F. (1999) · Oncogene · doi:10.1038/sj.onc.1202349 · Cited by 329
Lu, R., Nash, H. M., & Verdine, G. L. (1997) · Current Biology · doi:10.1016/s0960-9822(06)00187-4 · Cited by 323
(2003) · PubMed · Cited by 313
Cancer and aging: a model for the cancer promoting effects of the aging stroma
Krtolica, A., & Campisi, J. (2002) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/s1357-2725(02)00053-5 · Cited by 295
Clinical implications and utility of field cancerization
Dakubo, G. D., Jakupciak, J. P., Birch-Machin, M. A., & Parr, R. L. (2007) · Cancer Cell International · doi:10.1186/1475-2867-7-2 · Cited by 294
Hypermethylation of 14-3-3 σ (stratifin) is an early event in breast cancer
Umbricht, C. B., Evron, E., Gabrielson, E., Ferguson, A. T., Marks, J., & Sukumar, S. (2001) · Oncogene · doi:10.1038/sj.onc.1204438 · Cited by 291
Loss of imprinting in normal tissue of colorectal cancer patients with microsatellite instability
Cui, H., Horon, I. L., Ohlsson, R., Hamilton, S. R., & Feinberg, A. P. (1998) · Nature Medicine · doi:10.1038/3260 · Cited by 284
Wu, Y., Halverson, G., Basir, Z., Strawn, E., Yan, P., & Guo, S.-W. (2005) · American Journal of Obstetrics and Gynecology · doi:10.1016/j.ajog.2005.01.034 · Cited by 283
Laser capture microdissection in pathology: Figure 1
Fend, F., & Raffeld, M. (2000) · Journal of Clinical Pathology · doi:10.1136/jcp.53.9.666 · Cited by 275
Wagner, K.-U., Boulanger, C. A., Henry, M. D., Sgagias, M., Hennighausen, L., & Smith, G. H. (2002) · Development · doi:10.1242/dev.129.6.1377 · Cited by 274
Fackler, M. J., McVeigh, M., Mehrotra, J., Blum, M. A., Lange, J., Lapides, A., Garrett, E., Argani, P., & Sukumar, S. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3341 · Cited by 270
Methylation and Silencing of the Retinoic Acid Receptor- 2 Gene in Breast Cancer
Widschwendter, M., Berger, J., Hermann, M., Muller, H. M., Amberger, A., Zeschnigk, M., Widschwendter, A., Abendstein, B., Zeimet, A. G., Daxenbichler, G., et al. (2000) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/92.10.826 · Cited by 259
Pathologic progression of autochthonous prostate cancer in the TRAMP model
Gingrich, Jr., Barrios, R., Foster, B., & Greenberg, N. (1999) · Prostate Cancer and Prostatic Diseases · doi:10.1038/sj.pcan.4500296 · Cited by 253
Vaidya, J. S., Baum, M., Tobias, J. S., D’Souza, D. P., Naidu, S. V., Morgan, S., Metaxas, M., Harte, K. J., Sliski, A. P., & Thomson, E. (2001) · Annals of Oncology · doi:10.1023/a:1011609401132 · Cited by 225
“quadrant [6].”
Fibronectin Expression Modulates Mammary Epithelial Cell Proliferation during Acinar Differentiation
Williams, C. M., Engler, A. J., Slone, R. D., Galante, L. L., & Schwarzbauer, J. E. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2673 · Cited by 195
“In breast and other cancers, histologically normal tissues adjacent to tumors have been found to harbor the same genetic abnormalities as the tumor cells (4, 5), further supporting the notion that the microenvironment contributes to oncogenic phenotypes.”
BackgroundChromosomal Deletions and Tumor Suppressor Genes in Prostate Cancer
Dong, J.-T. (2001) · Cancer and Metastasis Reviews · doi:10.1023/a:1015575125780 · Cited by 192
“It can also occur in early stages of carcinogenesis, as deletion has been detected in normal cells [7].”
BackgroundFox, S. B., Generali, D. G., & Harris, A. L. (2007) · Breast Cancer Research · doi:10.1186/bcr1796 · Cited by 182
“Interestingly, normal breast adjacent to malignant breast induced angiogenesis twice as frequently as did tissues from non-neoplastic breast, suggesting that the angiogenic switch occurs before morphological changes are identifiable [10].”
BackgroundMeeker, A. K., Hicks, J. L., Gabrielson, E., Strauss, W. M., De Marzo, A. M., & Argani, P. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63180-x · Cited by 140
High-Dimensional Phenotyping Identifies Age-Emergent Cells in Human Mammary Epithelia
Pelissier Vatter, F. A., Schapiro, D., Chang, H., Borowsky, A. D., Lee, J. K., Parvin, B., Stampfer, M. R., LaBarge, M. A., Bodenmiller, B., & Lorens, J. B. (2018) · Cell Reports · doi:10.1016/j.celrep.2018.03.114 · Cited by 58
“A biological explanation of advanced effective age in epithelia could be that molecular states that are associated with risk exert field effects (Deng et al., 1996), which alter the epithelia through a dynamic and reciprocal communication between stroma and epithelia.”
BackgroundBERMAN, H., ZHANG, J., CRAWFORD, Y. G., GAUTHIER, M. L., FORDYCE, C. A., McDERMOTT, K. M., SIGAROUDINIA, M., KOZAKIEWICZ, K., & TLSTY, T. D. (2005) · Cold Spring Harbor Symposia on Quantitative Biology · doi:10.1101/sqb.2005.70.051 · Cited by 51
Metadata
- Authors
- Deng, G., Lu, Y., Zlotnikov, G., Thor, A. D., & Smith, H. S.
- Venue
- Science
- Published
- 1996-12-20
- Volume
- 274
- Issue
- 5295
- Pages
- 2057-2059
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2041988832
- Cited by
- 582
- References
- 15
- FWCI
- 22.37
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.